CD8A and neoplasm: The liver NKT cells activated with α-GalCer produce IFN-γ (as well as IL-4) to activate NK cells and CD8+ CD122+ T cells to acquire antitumor cytotoxicity, and tumor-specific CD8+ T cells are finally induced [4], [20].